A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations.
|Articles|January 23, 2008
New HIV drug approved on accelerated basis
Tibotec's Intelence is approved for use with other antiretrovirals to treat HIV
Advertisement
Tibotech Therapeutics' Intelence (etravirine) has been approved on an accelerated basis by the FDA for HIV combination therapy. The tablet is the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) to be introduced in nearly 10 years and also the first NNRTI to show antiviral activity in patients with NNRTI-resistant virus. As such, it breaks new ground in the treatment of HIV patients, said Tibotec, a division of Ortho Biotech Products.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.
A guide built from conversations with pharmacists on social media and independent pharmacy owners.
Exploring the effects of weight-loss and GLP-1 therapies, researchers determine the specific metabolic determinants that lead to patients’ weight reduction.
Observed by APhA and ASHP since 2023, bipartisan support has garnered to give pharmacy workforce suicide awareness its own federally recognized day.
Atogepant reduced migraine days during the perimenstrual period, positioning the medication as a potential first treatment option for the condition.
Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs.
Advertisement
Advertisement
Trending on Drug Topics
1
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
2
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
3
Generic Drug Costs Burdening Patients as Much as Brand Name Options
4
Social Media Best Practices for Pharmacists: Why Visibility Matters
5